Designs and Syntheses of Oxathiin Carboxanilide Analogues and their Antiviral Activities

Archives of Pharmacal Research

Volumn 23, Issue 4, 2000, Pages 315-323

  Hahn, Hoh Gyu ^a   Rhee, Hee Kyung ^a   Lee, Chong Kyo ^b   Whang, Kyu Ja ^c  

^a Korea Institute of Science and Technology   (South Korea)

^b Korea Research Institute of Chemical Technology   (South Korea)

^c Sookmyung Women's University   (South Korea)

Author keywords

Antiviral activities; Dithiins; Heterocyclic carboxanilide; Oxathiins; Thiazines; Thiocarboxanilides

Indexed keywords

ANTIVIRUS AGENT; CARBOXIN; DRUG DERIVATIVE; NSC 615985;

ARTICLE; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS 1; POLIOMYELITIS VIRUS; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANTIVIRAL AGENTS; CARBOXIN; HIV-1; POLIOVIRUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034251912     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02975440     Document Type: Article

References (17)

1. Bader, J. P., McMahon, J. B., Schultz, R. J., Narayanan, V. L., Pierce, J. B., Harrison, W. A., Weislow, O. S., Midelfort, C. F., Stinson, S. F. and Boyd, M. R., Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction. Proc. Natl. Acad. Sci. USA, 88, 6740-6744 (1991).
2. Balzarini, J., Jonckheere, H., Harrison, W. A., Dao, D. C., Anné, J., De Clercq, E. and Karlsson, A., Oxathiin carboxanilide derivatives: a class of non-nucleoside HIV-1-specific reverse transcriptase inhibitors (NNRTIs) that are active against mutant HIV-1 strains resistant to other NNRTIs. Antivir. Chem. Chemother., 6(3), 169-178 (1995).
3. Cava, M. P. and Levinson, M. I., Thionation reactions of Lawesson's reagents. Tetrahedron 41(22), 5061-5087 (1985).
4. De Clercq, E., The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection, Antiviral. Res., 38, 153-179 (1998).
5. Esnouf, R. M., Stuart, D. I., De Clercq, E., Schwartz, E. and Balzarini, J., Models which explain the inhibition of reverse transcriptase by HIV-1-specific (thio)carboxanilide derivatives. Biochem. Biophys. Res. Commun., 234, 458-464 (1997).
6. Harrison, W. A., Jewell, C. E., Felauer, E. E., Dekeyser, M. A., Cong, D. D., McGuiness, J. A., Mishra, A., Brouwer, W. G. and McPhee, D. J., Treatment of HIV infections and compounds useful therein. WO 97/05767, (1991).
7. Lee, C. K., Kim, D. K., Kim, J. H., Kim, H. S., Pi, M. K., Park, J. B. and Kim, B., In vitro evaluation of antihuman immunodeficiency virus activity of nucleoside derivatives and studies on their mode of action. J. Kor. Soc. Virol., 27(1), 69-75 (1997).
8. Lee, W. S., Lee, K., Nam, K. D. and Kim, Y. J., Rearrangement mechanisms of 1,3-dithiolane sulfoxides. Tetrahedron, 47(38), 8091-8110 (1991).
9. Levy, J. A., Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev., 57(1), 183-289, 1993.
10. Mah, H. D., Nam, K. D. and Hahn, H. G., Unexpected rearrangement of dihydro-1,4-thiazine. Bull. Korean. Chem. Soc., 18(6), 563-564 (1997).
11. Mitsuya, H., Broder, S., Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotropic virus type III/limphadeno pathy-associated virus (HTLV-III/ LAV) by 2′,3′-dideoxynucleosides. Proc. Natl. Acad. Sci. USA, 83, 1911-1915 (1986).
12. Mitsuya, H., Weinhold, K. J., Furman, P. A., St. Clair, M. H., Lehrman, S. N., Gallo, R. C., Bolognesi, D., Barry, D. W. and Broder, S., 3′-Azido-3′-deoxythymidine (BW A509U): An antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc. Natl. Acad. Sci. USA, 82, 7096-7100 (1985).
13. Pauwels, R., Andries, K., Desmyter, J., Schols, D., Kukla, M. J., Breslin, H. J., Raeymaeckers, A., van Gelder, J., Woestenborghs, R., Heykants, J., Schellekens, K., Janssen, M. A. C., De Clercq, E. and Janssen, P. A. J., Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature, 343, 470-474 (1990).
14. Pauwels, R., Balzarini, J., Baba, M., Snoeck, R., Schols, D., Herdewijn, P., Desmyter, J. and De Clercq, E., Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods 20, 309-321 (1988).
15. Ren, J., Esnouf, R. M., Hopkins, A. L., Warren, J., Balzarini, J., Stuart, D. I. and Stammers, D.K. Crystal structures of HIV-1 reverse transcriptase in complex with carboxanilide derivatives. Biochemistry, 37(41), 14394-14403 (1998).
16. Tantillo, C., Ding, J., Jacobo-Molina, A., Nanni, R. G., Boyer, P. L., Hughes, S. H., Pauwels, R., Andries, K., Janssen, P. A. J. and Arnold, E., Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. J. Mol. Biol., 243, 369-387 (1994).
17. Tucker, T. J., Lumma, W. C. and Culberson, J. C., Development of nonnucleoside HIV reverse transcriptase inhibitors. Methods Enzymol., 275, 440-472 (1996).